Stocks to Watch: Apollo Hospitals, Reliance Industries, Aditya Birla Capital, RVNL in Focus After Key Developments

Several stocks are likely to remain in focus in Thursday’s trading session after reporting quarterly earnings, securing fresh orders, announcing strategic partnerships, and unveiling expansion plans.

Apollo Hospitals Enterprise

Apollo Hospitals Enterprise reported a strong set of earnings for the fourth quarter on a consolidated basis. The healthcare major posted a 35.9% year-on-year jump in net profit to ₹529.3 crore compared to ₹389.6 crore in the corresponding quarter last year.

Revenue from operations increased 18.1% YoY to ₹6,605.5 crore against ₹5,592.2 crore in the year-ago period. The healthy performance was supported by growth across hospital operations, pharmacy, and healthcare services businesses. The strong earnings performance is expected to keep the stock in focus.

Sammaan Capital

Sammaan Capital reported a sharp deterioration in its quarterly earnings performance. The company posted a massive consolidated loss of ₹8,101.4 crore in Q4 compared to a loss of ₹324.04 crore in the same period last year.

Revenue declined 35.6% year-on-year to ₹1,357.7 crore from ₹2,107.4 crore. The weak performance was largely due to a significant rise in impairment on financial instruments, which stood at ₹2,958.1 crore compared to ₹288.86 crore a year ago.

The company also reported an exceptional loss of ₹6,499.2 crore during the quarter against nil exceptional loss in the previous year period, making the stock one of the key names to watch.

Reliance Industries

Reliance Industries will remain on investors’ radar after its wholly-owned subsidiary, RISE Worldwide, announced a strategic partnership with Major League Baseball (MLB) to support the growth of baseball in India.

The collaboration will include joint efforts across marketing, social media engagement, and commercial initiatives. As part of the partnership, RISE and MLB will also jointly deliver a live baseball event in Mumbai in October 2026. The development highlights Reliance’s continued expansion in the sports and entertainment ecosystem.

HG Infra Engineering

HG Infra Engineering said it has decided not to include projects worth ₹4,142 crore in its executable order book due to uncertainty regarding project execution.

The company stated that further clarity is awaited from the Maharashtra State Road Development Corporation (MSRDC). The announcement may weigh on investor sentiment as concerns around execution visibility and order conversion remain.

Rail Vikas Nigam

Rail Vikas Nigam Limited (RVNL) has emerged as the lowest bidder for a project worth ₹164.18 crore from East Coast Railway.

The order win further strengthens RVNL’s project pipeline and reinforces its presence in railway infrastructure development. Investo₹are expected to track further updates regarding formal award and execution timelines.

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals will be in focus after Ichnos Glenmark Innovation (IGI) announced a new development candidate, ISB 2301, aimed at treating multiple solid tumour indications.

The company said ISB 2301 is a first-in-class multispecific immune cell activator that targets three tumour-associated antigens to trigger tumour cell death. It also activates both T cells and NK cells to enhance the immune system response, marking an important advancement in the oncology segment.

JK Cement

JK Cement received a Letter of Intent (LoI) from the Government of Andhra Pradesh for the grant of a limestone mining lease in the Dommarnandyala Block-3 Limestone Block located in YSR Kadapa district.

The mining lease spans an area of 1,188 hectares and is expected to support the company’s long-term raw material security and expansion plans in the cement business.

Pace Digitek

Pace Digitek secured an advance work order worth ₹264.6 crore from Bharat Sanchar Nigam Limited (BSNL).

The order involves the design, supply, construction, installation, upgradation, operation, and maintenance of middle-mile and last-mile network infrastructure under the BharatNet programme in the Sikkim telecom circle. The project is expected to strengthen the company’s order book and telecom infrastructure presence.

Aditya Birla Capital

Aditya Birla Capital announced that its Board of Directo₹has approved a preferential issuance aggregating ₹4,000 crore to strengthen the company’s capital base.

The proposed issuance includes ₹2,880 crore to promoter entity Grasim Industries, ₹200 crore to Suryaja Investment Pte Limited, Singapore, and ₹920 crore to International Finance Corporation (IFC).

The preferential allotment will be undertaken at a price of ₹356.02 per share. The company said the proceeds will be used for growth objectives, including capital augmentation for the lending business and other general corporate purposes.